Comfortable leader
17 companies value 35 bn revenue 17 bn margin -0.6% free cash flow 2.3 bn avg. score 1.5
ZBH holds 51.6% of the group's value, 1.8x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBH | Zimmer Biomet United States · score 6.4 | 52% | 18 bn | 8.5 bn | 9.5% | 1.5 bn | 8.4% | 1.0% | Knee, hip and spine orthopedic implants · Global top 2 in knee and hip implants | |
| 2 | GMED | Globus Medical United States · score 6.5 | 29% | 10 bn | 3.1 bn | 17.0% | 0.8 bn | 7.4% | — | Implants and robotics for spine surgery · Leader in spine implants and robotics | |
| 3 | ATEC | Alphatec Holdings United States · score 0.0 | 5% | 1.6 bn | 0.8 bn | -13.5% | 0.0 bn | 0.1% | — | Implants and instruments for spine surgery · Spine implants, growing faster than the sector | |
| 4 | ENOV | Enovis CORP United States · score 1.9 | 3% | 1.1 bn | 2.3 bn | -48.0% | 0.1 bn | 5.6% | — | Medical technology for reconstructive surgery and rehabilitation · Texas — revenue of $2.3bn | |
| 5 | BVS | Bioventus Inc. United States · score 6.3 | 3% | 0.9 bn | 0.6 bn | 9.4% | 0.1 bn | 10.5% | — | Medical devices for pain and musculoskeletal problems · North Carolina — revenue of $582m | |
| 6 | SIBN | SI-BONE, Inc. United States · score 0.5 | 3% | 0.9 bn | 0.2 bn | -6.9% | 0.0 bn | -0.5% | — | Implants for sacroiliac joint fusion · California — revenue of $214m | |
| 7 | KIDS | ORTHOPEDIATRICS CORP United States · score 0.5 | 2% | 0.6 bn | 0.3 bn | -15.7% | 0.0 bn | -0.3% | — | Pediatric orthopedic devices · Indiana — revenue of $253m | |
| 8 | OFIX | Orthofix Medical Inc. United States · score 0.0 | 1% | 0.4 bn | 0.8 bn | -7.4% | -0.0 bn | -7.1% | — | Orthopedic medical technology, from Lewisville, Texas · Texas — revenue of $833m | |
| 9 | SI | SHOULDER INNOVATIONS, INC. United States · score 0.1 | 1% | 0.4 bn | 0.1 bn | -58.3% | -0.1 bn | -12.4% | — | Shoulder surgery medical technology · Michigan — revenue of $60m | |
| 10 | CARL | CARLSMED, INC. United States · score 0.1 | 1% | 0.4 bn | 0.1 bn | -57.4% | -0.0 bn | -9.3% | — | AI-personalized spine implants · California — revenue of $63m | |
| 11 | TMCI | TREACE MEDICAL CONCEPTS, INC. United States · score 0.0 | 1% | 0.3 bn | 0.2 bn | -29.0% | -0.0 bn | -9.9% | — | Implants and instruments for bunion surgery · Florida — revenue of $205m | |
| 12 | ANIK | Anika Therapeutics, Inc. United States · score 2.6 | 1% | 0.3 bn | 0.1 bn | -3.1% | 0.0 bn | 0.2% | — | Hyaluronic acid products for orthopedics · Massachusetts — revenue of $121m | |
| 13 | XTNT | Xtant Medical Holdings, Inc. United States · score 0.6 | 0% | 0.0 bn | 0.1 bn | -10.2% | 0.0 bn | -1.7% | — | Medical technology of biologics and spine implants · Montana — revenue of $110m | |
| 14 | SINT | Sintx Technologies, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -848.2% | -0.0 bn | -80.7% | — | Silicon nitride for musculoskeletal medical devices · Utah — revenue of $1m | |
| 15 | RGNT | REGENTIS BIOMATERIALS LTD. Israel · score 0.0 | 0% | 0.0 bn | — | — | 0.0 bn | -36.9% | — | Hydrogel for cartilage repair, from Israel · Israel | |
| 16 | BBLG | Bone Biologics Corp United States · score 0.0 | 0% | 0.0 bn | — | — | 0.0 bn | -239.0% | — | Bone regeneration medical devices for spinal fusion · Massachusetts | |
| 17 | TNON | Tenon Medical, Inc. United States · score 0.0 | — | — | 0.0 bn | -257.9% | -0.0 bn | — | — | Medical devices for sacropelvic disorders · California — revenue of $5m |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.